Ads
related to: biomarker
Search results
In RA Treatment, Don't Overlook Underlying CV Risks
Medscape· 2 days agoPatients with rheumatoid arthritis (RA) carry a high risk for cardiovascular events, but mounting clinical evidence suggests they're being undertreated...
Scientists Unravel Genetic Basis for Neurodegenerative Disorders that Affect Vision, NIH Reports
Sierra Sun Times· 2 days agoLed by researchers at the National Institutes of Health (NIH), a team of scientists has uncovered the complex molecular mechanisms underlying neurodegenerative disorders linked to the gene PNPLA6 ...
Blood test may pick up on cerebral small vessel disease, stroke risk
Medical News Today· 5 days agoA new study proposes a type of blood test for predicting cerebral small blood vessel disease and,...
Lynx Dx Sees Possible Reimbursement on Horizon for PCR-Based Prostate Cancer Evaluation Test
GenomeWeb News· 4 days agoUniversity of Michigan spinout Lynx Dx anticipates favorable coverage decisions in 2024 from...
Adding cardiovascular biomarkers to established risk factors increases risk prediction
Medical Xpress· 3 days agoThe addition of cardiovascular biomarkers to established risk factors leads to a small improvement...
Cytokinetics Reverses Higher On 'Pristine' Results For Bristol Myers-Rivaling Heart Drug
Investor's Business Daily· 3 days agoDoctors recommend SRT for patients with hypertrophic cardiomyopathy when a medicine fails to control...
AbbVie Presents New Data Supporting Leading Gastroenterology Portfolio at 2024 Digestive Disease...
WKBN 27 Youngstown· 16 hours ago...bowel diseases (IBD)- Data to be presented from the SEQUENCE head-to-head trial comparing risankizumab (SKYRIZI®) versus ustekinumab (STELARA®) in Crohn's disease include an economic analysis and oral presentation that assessed inflammation biomarkers - Additional presentations include efficacy...
Long Covid: the cause, the consequence, the future of clinical trials
Clinical Trials Arena via Yahoo Finance· 2 days agoImperial College London hopes its recently published Long Covid study will lead to further clinical...
Earnings call: Plus Therapeutics reveals Q1 2024 financials, clinical progress By Investing.com
Investing.com· 2 days agoPlus Therapeutics, Inc. (NASDAQ:PSTV) announced its first quarter 2024 financial results and...
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate...
WJTV Jackson· 3 days agoBrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the First Quarter ...